Cytokinetics, Incorporated (CYTK)
NASDAQ·Healthcare·Biotechnology
$73.95
+0.45%
Mkt Cap $9.05B
Analyst Ratings
Buy
20
Hold
0
Sell
0
Price Target (51 analysts)
$107.80
Range $84.00 – $140.00
Implied Upside
+45.8%
Consensus $107.80 vs current $73.95
NASDAQ·Healthcare·Biotechnology
$73.95
+0.45%
Mkt Cap $9.05B
Buy
20
Hold
0
Sell
0
Price Target (51 analysts)
$107.80
Range $84.00 – $140.00
+45.8%
Consensus $107.80 vs current $73.95